MedTrace Logo

Shock-Waves to Treat Fibromyalgia Pain

NCT03088215 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2017-10-09

No results posted yet for this study

Summary

Fibromyalgia pain syndrome is a common debilitating condition which associates mainly generalised pain, emotional distress and cognitive symptoms. The etiology is unknown, and no specific treatment exists so far.

Lately, shock-waves have been used successfully to treat painful skeletal muscle, tendons and fascia, the investigators therefore hypothesize that shock-waves could be useful in alleviating Fibromyalgia pain.

Two similar groups of participants bearing the condition will be prospectively compared.

The first group will benefit from the application of shock-waves weekly for 12 weeks, the second will not.

The investigators intend to study if there is any difference in pain and quality of life between the two groups at the end of the three months.

Conditions

  • Fibromyalgia
  • Myofascial Pain Syndrome
  • MSK: Chronic Pain Syndromes (E.G. Fibromyalgia)
  • Central Sensitization

Interventions

DEVICE

shock-waves

Application of shock-waves (radial and focused)

Sponsors & Collaborators

  • Projet Suisse d'Assistance Medicale

    collaborator OTHER

  • Dr Yves JACOT, MD

    lead OTHER

Principal Investigators

  • Dr Yves JACOT, MD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-20
Primary Completion
2018-11-20
Completion
2018-11-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03088215 on ClinicalTrials.gov